Your browser doesn't support javascript.
loading
Prevalence of Body Dysmorphic Disorder in Private Aesthetic Clinical Settings in Four Latin American Countries: A Cross-Sectional Study.
Villafranca, Jorge; Diaz, Gabriel; Rengifo, Jaime; Ramos, Mónica; Cella, Gabriella; Zuluaga, Julio Ricardo.
Afiliação
  • Villafranca J; Dr. Jorge Villafranca, Private Practice, Av. Las Condes 9460, Office 1001, 7591092, Santiago, Chile. jorvillafar@gmail.com.
  • Diaz G; Plastic Surgery Residency Program, Universidad de Chile, Santiago, Chile.
  • Rengifo J; Dermatology Residency Program, Universidad Pontificia Bolivariana, Medellín, Colombia.
  • Ramos M; Dermika, Laser Dermatology Center, Guadalajara, México.
  • Cella G; Skin Center Rosario, Rosario, Argentina.
  • Zuluaga JR; Odds Epidemiology, Bogotá, Colombia.
Aesthetic Plast Surg ; 2024 Jun 19.
Article em En | MEDLINE | ID: mdl-38898241
ABSTRACT

BACKGROUND:

Body dysmorphic disorder (BDD) is a psychiatric condition characterized by persistent concern with non-existent or minor defects in one's physical appearance. BDD can be difficult to identify as patients often have limited insight into the condition.

OBJECTIVE:

We aimed to determine the prevalence of BDD in patients presenting to private aesthetic clinical settings in four Latin American countries.

METHODS:

We conducted a cross-sectional study From August to October 2022 to evaluate the prevalence of BDD among 360 patients seeking nonsurgical cosmetic procedures in Chile, Mexico, Argentina, and Colombia using the Dysmorphic Concern Questionnaire (DCQ). We reported prevalence estimates for the lowest and highest previously proposed DCQ cutoff points.

RESULTS:

The DCQ total scores in the study population ranged from 0 to 21, with a mean total score of 5.1 ± 3.4. The prevalence of positive screening results for BDD (total DCQ score ≥ 9) was 15.8%. The prevalence of a likely diagnosis of BDD (total DCQ score of ¥ 17) was 0.83%.

LIMITATIONS:

The convenience sample limited the generalizability of the findings to Latin America.

CONCLUSION:

We encourage colleagues to be more mindful of this diagnosis and to facilitate earlier psychological evaluation in patients who are positive for BDD. LEVEL OF EVIDENCE III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article